Johnson & Johnson Ordered to Pay $417M to Woman Diagnosed with Ovarian Cancer
A jury in Los Angeles, California ordered Johnson & Johnson to pay $417 million in damages to a woman who was diagnosed with ovarian cancer after using Johnson & Johnson’s Baby Powder for feminine hygiene for decades. The lawsuit alleged that Johnson & Johnson failed to warn women about increased risks for ovarian cancer linked to the use of talcum-based products including Johnson’s Baby Powder and Shower to Shower products. Nearly 5,000 women have claims pending against the manufacturer.
This latest verdict brings the total of damages that courts have ordered Johnson & Johnson to pay to more than $724 million. Three other jury trials issued verdicts of $72 million, $70.1 million and $55 million over the past couple of years.
Clinical studies have found that talc use increased the risk for ovarian cancer by 30-60% in “almost all well-designed studies” according to a finding by the International Journal of Gynecological Cancer published in May 2015.
Cohen & Malad, LLP is representing hundreds of women across the United States who have used Johnson & Johnson’s Baby Powder and Shower to Shower talcum powder products for feminine hygiene and have been diagnosed with ovarian cancer. If you or someone you know contact us for a free case evaluation.